1993
DOI: 10.2307/27671085
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of an Inactivated Avian Polyomavirus Vaccine

Abstract: JSTOR is a not-for-profit service that helps scholars, researchers, and students discover, use, and build upon a wide range of content in a trusted digital archive. We use information technology and tools to increase productivity and facilitate new forms of scholarship. For more information about JSTOR, please contact support@jstor.org.. Association of Avian Veterinarians is collaborating with JSTOR to digitize, preserve and extend access to

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
10
0
1

Year Published

1995
1995
2007
2007

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(11 citation statements)
references
References 9 publications
0
10
0
1
Order By: Relevance
“…Psittacine birds should be vaccinated with the commercially available, fully licensed vaccine Psittimune (Biomune). This inactivated vaccine is administered subcutaneously and has been proven to be safe and effective [41,42]. Generally, young birds are vaccinated starting at 5 weeks of age and are protected optimally at 2 weeks after the second vaccine.…”
Section: Polyomavirinaementioning
confidence: 99%
“…Psittacine birds should be vaccinated with the commercially available, fully licensed vaccine Psittimune (Biomune). This inactivated vaccine is administered subcutaneously and has been proven to be safe and effective [41,42]. Generally, young birds are vaccinated starting at 5 weeks of age and are protected optimally at 2 weeks after the second vaccine.…”
Section: Polyomavirinaementioning
confidence: 99%
“…VP4 deletion mutants of APV have been considered as vaccine candidates to be used against the APVinduced disease in parrots (39). As efficient and safe vaccines are urgently needed against the diseases caused by APV and GHPV, the VP4 deletion mutants as live-attenuated vaccines should be tested in parallel to classical vaccines based on inactivated virus (69) or recombinant vaccines based on viruslike particles (37,86).…”
Section: Pathogenesis Of Diseases Caused By Polyomaviruses Of Birdsmentioning
confidence: 99%
“…In non-budgerigar psittacines, detection of anti-polyomavirus antibodies in a single serum sample merely indicates a previous infection (Ritchie et al, 1997b). The demonstration of a progressively decreasing antibody titre in multiple groups of naturally infected non-budgerigar psittacines suggests that most infected birds are able to mount an effective immune response and clear the infection Wainwright et al, 1987;Ritchie et al, 1996Ritchie et al, , 1997b.…”
mentioning
confidence: 99%
“…In non-budgerigar psittacines, detection of anti-polyomavirus antibodies in a single serum sample merely indicates a previous infection (Ritchie et al, 1997b). The demonstration of a progressively decreasing antibody titre in multiple groups of naturally infected non-budgerigar psittacines suggests that most infected birds are able to mount an effective immune response and clear the infection Wainwright et al, 1987;Ritchie et al, 1996Ritchie et al, , 1997b. Theoretically, polyomavirus infections in a flock could be prevented by screening all the birds for antibodies, eliminating those that are seropositive, repeatedly disinfecting all potentially contaminated surfaces in the aviary and reducing the potential for virus exposure by maintaining a completely closed aviary.…”
mentioning
confidence: 99%
See 1 more Smart Citation